4
Changes in Ownership
Inmune Bio, Inc. Filed Acc 0001213900-25-112229
Options or other derivatives
- Director acquired 366,000 shares (grant or award)
- Director returned 366,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Ganjei James Kelly · Director
Table II: Derivative
16 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-18 | Returned to the company : show line 1 in the form Stock Option (right to buy) | −108,000 | 0 | D |
| 2025-11-18 | Grant or award : show line 2 in the form Stock Option (right to buy) | +108,000 | 108,000 | D |
| 2025-11-18 | Returned to the company : show line 3 in the form Stock Option (right to buy) | −108,000 | 0 | D |
| 2025-11-18 | Grant or award : show line 4 in the form Stock Option (right to buy) | +108,000 | 108,000 | D |
| 2025-11-18 | Returned to the company : show line 5 in the form Stock Option (right to buy) | −15,975 | 0 | D |
| 2025-11-18 | Grant or award : show line 6 in the form Stock Option (right to buy) | +15,975 | 15,975 | D |
| 2025-11-18 | Returned to the company : show line 7 in the form Stock Option (right to buy) | −19,025 | 0 | D |
| 2025-11-18 | Grant or award : show line 8 in the form Stock Option (right to buy) | +19,025 | 19,025 | D |
Loading xslF345X05/ownership.xml…